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Abstract
A patient was admitted for fever and acute respiratory failure (ARF), rapidly progressive tetraparesis, delirium, behavioral abnormalities,
and diplopia. Leukocytosis and a rise in C-reactive protein were present. A syndrome of inappropriate anti-diuretic hormone secretion
(SIADH) was also diagnosed. Lumbar puncture yielded colorless CFS with mononuclear pleocytosis and protein rise. Electrodiagnosis
revealed demyelinating polyneuropathy and axonal degeneration. Serum IgG and IgM for mycoplasma pneumoniae (MP) was consistent with
acute infection, and erythromycin was started with rapid resolution of symptoms. Contrarily to most reports, an associated respiratory disease
was not present and SIADH in association with MP has been reported only once, in a patient without direct central nervous system (CNS)
involvement. Differential diagnosis and possible pathogenic mechanisms are discussed.
© 2003 Elsevier B.V. All rights reserved.
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1. Introduction
In most series, neurological complications have been
diagnosed in 2–5% of patients with pneumonia due to
mycoplasma pneumoniae (MP) [1–3], typically presenting
within a few weeks of respiratory symptoms [3]. Long-term
sequelae can occur in up to 20–30% of the cases [1]. En-
cephalitis was the most frequent manifestation in one series
[4], and is the most reported in single case reports [5],
but meningitis, brainstem syndromes, myelitis, cranial, and
peripheral neuropathies, Guillain–Barré Syndrome (GBS),
and acute disseminated encephalomyelitis (ADEM) are
also possible [1]. Immunological and direct invasion are
possible mechanisms of disease [1,3,5]. Only a few reports
described neurological manifestations of MP in the absence
of pneumonia [6,7], most in children. SIADH was once as-
sociated with MP pneumonia [8]. We report a patient with
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neurological involvement and SIADH attributed to MP, in
the absence of respiratory disease.
2. Case report
A previously healthy 30-year-old male was admitted after
a 7-day history of fever, delirium, behavioral abnormalities,
facial paresis, diplopia, weakness of the right upper limb,
paraesthesia, and radicular pain of the left lower and the
right upper limbs and urinary retention. The patient de-
nied cough, expectoration, hemoptysis, dyspnea, nasal dis-
charge, chest pain, anorexia, and weight loss. Haemogram,
leukogram and C-reactive protein were normal, and serum
sodium 132 meq./l. Lumbar puncture yielded colorless CFS
under normal opening pressure, 30 cells (no predominance),
protein 154 mg/100 ml and glucose 57 mg/100 ml (serum
glucose 80 mg/100 ml); posteroanterior chest X-ray in the
upright position was normal; brain CT scan and MRI were
normal. The following day progression of tetraparesis and
acute respiratory failure (ARF) led to mechanical ventila-
tion. Vital signs were stable and axilar temperature 38 ◦C.
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Table 1
Evolution of serum M. pneumoniae serology, before and after erythromycin
Immunoglobin First serology Second serology Erythromycin Third serology
IgM 0.479 (positive titres if >0.477) 0.518 (positive titres if >0.383) – 0.466 (positive titres if >0.4)
IgG 0.384 (positive titres if >0.248) 0.571 (positive titres if >0.222) – 1.1 (positive titres if >0.223)
Chest examination showed normal respiratory excursions, a
resonant percussion, presence of normal breath sounds, ab-
sence of crackles or wheezing, and normal cardiac sounds.
He was sedated but could localize pain only with his left arm;
meningismus was absent. Pupillary and ocular fundi exami-
nations were normal. A bilateral peripheral facial paresis was
observed, and the examination of other cranial nerves was
unremarkable. He had a flaccid tetraparesis mainly of lower
limbs, both tendon and abdominal reflexes were weak and
he had bilateral flexor plantar responses. Within 4 days he
progressed to stupor, had spontaneous decerebrate posturing
of left upper limb, right third, and bilateral sixth nerve pare-
sis, paraplegia, absent tendon reflexes in lower limbs, and
no plantar responses. White cell count was 17.700 × 109 l
(neutrophil count 84%); C-reactive protein was 19, both
increasing in the following days; and serum sodium was
123 meq./l, decreasing further to 112 meq./l. Daily chest
X-ray consistently showed normal findings. A second lum-
bar puncture yielded colorless CFS, 104 cells (predomi-
nance of lymphocites), protein 116 mg/100 ml and glucose
65 mg/100 ml. Investigation of hyponatraemia disclosed an
increased urinary sodium concentration (533 mmol/24 h)
and low osmolality (233 mOSm/l), making the diagnosis of
SIADH, which was successfully treated with fluid restric-
tion, hypertonic solute administration, and furosemide.
First assumption was of an acute infection of central and
peripheral nervous system. No growth of bacteria, virus
or mycoplasma was detected in sputum, blood, urine, and
CSF cultures, including mycobacteria. Serologic tests for
M. pneumoniae antibody IgG and IgM were positive, with a
gradual increase of IgG, consistent with ongoing infection
(Table 1). Polymerase chain reaction (PCR) for MP in the
CSF was not possible because of logistics. Cold agglutinins
were not studied. Serodiagnosis for Lyme disease, syphilis,
adenovirus, mumps, Q-fever, coxsackie A and B, measles
viruses, epstein-barr, herpes simplex, varicella-zoster, cy-
tomegalovirus, influenza A and B, and HIV 1 and 2 were
negative. The diagnosis of GBS, ADEM, vasculitis, por-
phyria, arsenic, and lead intoxication were also considered,
but specific work-up was negative, as well as auto-antibodies
to gangliosides and galactocerebrosides. Nerve conduction
studies and electromyography revealed absent F-responses,
increased distal latencies, slowing of nerve conduction ve-
locities, decreased amplitude of evoked motor responses,
absence of sensory nerve potentials, in lower and up-
per limbs, and presence of fibrillation potentials (+3) at
the abductor pollicis brevis, suggestive of demyelinating
sensitive-motor polyneuropathy with axonal degeneration.
EEG showed only minor abnormalities. A second MRI of
brain and spine revealed piamater and arachnoid enhance-
ment surrounding conus medullaris and cauda equina, indi-
cating a focal inflammatory lesion, probably due to spinal
tap.
A diagnosis of probable acute infection of central and pe-
ripheral nervous system by MP was made, and erythromycin
1 g qid for 21 days was started, with rapid resolution of neu-
rological symptoms, along with a decrease in leukocytosis
and C-reactive protein. At discharge the patient examination
disclosed a bilateral VII nerve palsy, a flaccid tetraparesis of
grade 4/5 and distal paraesthesia of all limbs. At 3 months
follow-up, the patient was able to walk with cane assistance,
had a mild bilateral VII nerve palsy and paraesthesia of dis-
tal legs.
3. Discussion
The case here described is interesting because it was pos-
sible to document a widespread lesion of the central and pe-
ripheral nervous system by acute MP infection, as evidenced
by serologic profile of MP antibodies and a clear temporal
relationship between beginning of erythromycin and reso-
lution of neurological symptoms. In our patient, the tetra-
paresis and ARF were responsible for admission in intensive
care unit, making it a rare but important differential diag-
nosis for causes of rapidly progressing motor weakness and
ARF. Contrarily to most reports, our patient did not have a
respiratory infection and so an infection limited to nervous
system was present. The absence of respiratory symptoms,
the normal findings in chest examination and in daily chest
X-ray consistently excluded a respiratory tract infection. To
our knowledge, the association of SIADH and MP was only
reported once [6], in a patient with pneumonia who devel-
oped SIADH and in whom seizures and stupor state were
present during hyponatraemia, with no documented nervous
system lesion. In our case, SIADH seems to be in direct
relation with the meningoencephalitis.
Pathogenesis of neurological disease associated with MP
is poorly understood but autoimune response or direct in-
vasion are commonly cited possibilities [1,3,5]. In this case
we cannot draw a firm conclusion about pathogenesis since
it was not possible to document the presence of MP in ner-
vous system. Nevertheless, the mechanism of direct invasion
would be the most likely based on the serologic profile of
acute infection by MP, the simultaneous progression of neu-
rological deficit and increase in infectious analytic param-
eters, and the presence of clinical and laboratory apparent
benefit after erythromycin treatment.
M. Coelho et al. / Clinical Neurology and Neurosurgery 106 (2004) 129–131 131
M. pneumoniae may cause severe nervous system disor-
ders and long-term neurological sequelae, making early di-
agnosis and treatment very important.
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